Aurora enjoys a profitable new dawn in international medical cannabis markets

Canadian company Aurora Cannabis has seen continued growth in its international business thanks to an increasing presence in emerging medical cannabis markets.

“Our leadership in key markets such as Germany, the UK, Australia and Poland demonstrates our unique, portable and profitable international medical programme,” said CEO Miguel Martin. “We are beginning to see signs of stabilisation in our Canadian adult recreational segment and are excited about the contributions from the Thrive acquisition, which continues to advance our premiumisation strategy.”